Meriwether Wealth & Planning’s Moderna MRNA Stock Holding History

Meriwether Wealth & Planning’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.27K	Buy	+17	New	+$1.83K	﹤0.01%	576

Other funds holding MRNA

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Meriwether Wealth & Planning's MRNA Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Moderna (MRNA) in Q3 2026: 17 shares worth $3.27K. The stake represents ﹤0.01% of the portfolio and ranks #576 among its holdings.

287 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Meriwether Wealth & Planning held 17 shares of Moderna worth $3.27K as of Q3 2026.
Moderna was a new Meriwether Wealth & Planning position in Q3 2026.
Moderna made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #576 holding.
287 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.